Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Mutations in the gene encoding copper/zinc superoxide dismutase enzyme produce an animal model of familial amyotrophic lateral sclerosis (FALS), a fatal disorder characterized by paralysis. Overexpression of the proto-oncogene bcl-2 delayed onset of motor neuron disease and prolonged survival in transgenic mice expressing the FALS-linked mutation in which glycine is substituted by alanine at position 93. It did not, however, alter the duration of the disease. Overexpression of bcl-2 also attenuated the magnitude of spinal cord motor neuron degeneration in the FALS-transgenic mice.

[1]  J. Rothstein.  Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. , 1995, Advances in neurology.

[2]  Robert H. Brown,et al.  Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function , 1995, Current Opinion in Neurobiology.

[3]  M. Dubois‐Dauphin,et al.  Acute application of an interleukin‐1β‐converting enzyme‐specific inhibitor delays axotomy‐induced motoneurone death , 1996, Neuroreport.

[4]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[5]  P. Clarke,et al.  Bcl-2 regulates activation of apoptotic proteases in a cell-free system , 1996, Current Biology.

[6]  M. Gurney,et al.  Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  D. Troost,et al.  Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl‐2 expression is increased in unaffected post‐central gyrus , 1995, Neuropathology and applied neurobiology.

[8]  G. Schneider,et al.  Bcl-2 promotes regeneration of severed axons in mammalian CNS , 1997, Nature.

[9]  J. Morrison,et al.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  David S. Park,et al.  Ordering the Cell Death Pathway , 1996, The Journal of Biological Chemistry.

[11]  M. Raff,et al.  Programmed cell death and Bcl-2 protection in very low oxygen , 1995, Nature.

[12]  J. Belleroche,et al.  Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA , 1995, Brain Research.

[13]  David W. Anderson,et al.  Altered expression of bcl‐2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons , 1996, Annals of neurology.

[14]  S. Korsmeyer,et al.  Bcl-2 gene family in the nervous system. , 1997, Annual review of neuroscience.